Welcome to BONESUPPORT, you have come on to the International page, would you like to stay or be redirected to the US site?

BONESUPPORT AB is a Scandinavian orthobiologics company that develops and markets CERAMENT®, an innovative range of radiopaque injectable osteoconductive and drug-eluting bioceramic products that have a proven ability to heal defects by remodeling to host bone in six to twelve months.

Our products are effective in treating patients with fractures and bone voids caused by trauma, infection, disease or related surgery.

Latest Press Release

BONESUPPORT HOLDING AB (publ) – Q2 2019 Interim Report – invitation to conference call and webcast

18 July 2019

BONESUPPORT HOLDING AB (publ) – Q2 2019 Interim Report – invitation to conference call and webcast

Lund, Sweden, 08.00 am CET, 18 July 2019 – BONESUPPORT, an emerging leader in orthobiologics for the management of bone voids will publish its Q2 2019 Interim Report on 25 July 2019 at 08:00 am CET.

The Company will hold a conference call and an online presentation on the same day at 13.00 CET. The call will be hosted by Emil Billbäck, CEO and Håkan Johansson, CFO who will present the results and answer questions. The presentation will be held in English.

The dial-in numbers for the conference call are:

UK: +44 3333009274

SE: +46 856642695

US: +18335268382


The presentation will be webcasted and can be accessed from the following
web address:



BONESUPPORT (Nasdaq Stockholm: BONEX) develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient’s own bone and have the capability of eluting drugs. BONESUPPORT’s bone graft substitutes are based on the patented technology platform CERAMENT. The company is conducting several clinical studies to further demonstrate the clinical and health economic benefits its products deliver and a Premarket approval filing with the FDA (USA) for its gentamicin eluting product is planned in 2020. The company is based in Lund, Sweden, and the net sales amounted to SEK 97 million in 2018. Please visit for more information. 

BONESUPPORT and CERAMENT are registered trademarks of BONESUPPORT AB.


For more information contact:


Emil Billbäck, CEO
+46 (0) 46 286 53 70


Håkan Johansson, CFO
+46(0) 46 286 53 70


Cord Communications
Charlotte Stjerngren
+46 (0)708 76 87 87


Press release PDF (116.77 KB)


CERAMENT® | BONE VOID FILLER, formerly sold in the U.S. through Zimmer Biomet, is now sold exclusively by BONESUPPORT.

To order CERAMENT in the U.S., please call our Customer Service Department at 1-877-719-6718, or email:

You can learn more about the change in distribution here.